Universitat Politècnica de València. Departamento de Ingeniería Electrónica - Departament d'Enginyeria Electrònica, Instituto de Salud Carlos III, European Regional Development Fund, Ministerio de Economía y Competitividad, Marcos-Garces, Victor, Gavara, Jose, Monmeneu, Jose V., Lopez-Lereu, Maria P., Bosch, María J., Merlos, Pilar, Pérez, Nerea, Rios-Navarro, César, De Dios, Elena, Bonanad, Clara, Racugno, Paolo, Bellver Navarro, Alejandro, Ventura Perez, Bruno, Aguilar Botella, Jose, Ventura, Silvia, Moratal, David, Universitat Politècnica de València. Departamento de Ingeniería Electrónica - Departament d'Enginyeria Electrònica, Instituto de Salud Carlos III, European Regional Development Fund, Ministerio de Economía y Competitividad, Marcos-Garces, Victor, Gavara, Jose, Monmeneu, Jose V., Lopez-Lereu, Maria P., Bosch, María J., Merlos, Pilar, Pérez, Nerea, Rios-Navarro, César, De Dios, Elena, Bonanad, Clara, Racugno, Paolo, Bellver Navarro, Alejandro, Ventura Perez, Bruno, Aguilar Botella, Jose, Ventura, Silvia, and Moratal, David
[EN] OBJECTIVES: This study explored the association of ischemic burden, as measured by vasodilator stress cardiovascular magnetic resonance (CMR), with all-cause mortality and the effect of revascularization on all-cause mortality in patients with stable ischemic heart disease (SIHD). Background: In patients with SIHD, the association of ischemic burden, derived from vasodilator stress CMR, with all-cause mortality and its role for decision-making is unclear. METHODS: The registry consisted of 6,389 consecutive patients (mean age: 65 +/- 12 years; 38% women) who underwent vasodilator stress CMR for known or suspected SIHD. The ischemic burden (at stress first-pass perfusion imaging) was computed (17-segment model). The effect of CMR-related revascularization (within the following 3 months) on all-cause mortality was retrospectively explored using the electronic regional health system registry. RESULTS: During a 5.75-year median follow-up, 717 (11%) deaths were documented. In multivariable analyses, more extensive ischemic burden (per 1-segment increase) was independently related to all-cause mortality (hazard ratio: 1.04; 95% confidence interval: 1.02 to 1.07; p < 0.001). In 1,032 1:1 matched patients using a limited number of variables (516 revascularized, 516 non-revascularized), revascularization within the following 3 months was associated with less all-cause mortality only in patients with extensive CMR-related ischemia (>5 segments, n = 432; 10% vs. 24%; p = 0.01). CONCLUSIONS: In a large retrospective registry of unselected patients with known or suspected SIHD who underwent vasodilator stress CMR, extensive ischemic burden was related to a higher risk of long-term, all-cause mortality. Revascularization was associated with a protective effect only in the restricted subset of patients with extensive CMR-related ischemia. Further research will be needed to confirm this hypothesis-generating finding.